Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
KaloBios Provides Update on KB001-A Partnership and Clinical Status
IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p
U.S. FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
OHSU Knight Cancer Challenge attracts $100 million gift
BiologicTx® Announces Discovery 2 Life™ Platform (D2L™) and Three-Year Transplant Clinical Outcomes at The World Transplant Congress
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427
Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
"Graying" Population of Infertility Patients Brings New Challenges to Medical Practice and Society, Study at Center for Human Reproduction Finds
Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients
QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients
AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™
Parasites beware; National Center for Veterinary Parasitology at Oklahoma State University has its eyes on you
The Hepatitis C virus is the main cause of liver transplant in the world Spanish
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) for Treatment of Two Blood Cancers
Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™
Analysis of Human Gut Microbiome Provides New Opportunities for Liver Cirrhosis Diagnosis and Treatment
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer
DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment
Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)
Study Finds Pycnogenol® Effective In Improving Inner Ear Circulation With Relief Of Symptoms Of Meniere's Disease Including Tinnitus
Fast-Tracking the Global HIV Response - Day 5 at AIDS 2014
In RadioMD Interview, Dr. John Crew Describes Successful New Treatment for Flesh-Eating Disease
Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer
Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea
Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium
TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform Spanish
EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study
Debbie's Dream Foundation Continues to Be at the Forefront of Hastening Stomach Cancer Treatment Development and Assisting with Clinical Trials Enrollment
MedNet Appoints Clareece West As Chief Operating Officer
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
RVX-208 Reduces Major Adverse Cardiovascular Events (MACE) Significantly in Patients with Diabetes Mellitus English
Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects English
Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures
Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference
Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome
Restrospective Analysis Finds MiMedx EpiFix® As Most Effective In Rapid Resolution Of Diabetic Foot Ulcers When Compared With Two Other Skin Substitutes
Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials
Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
DripDrop Now Available At H-E-B
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices English
Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome
Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
Data from iPrEx Open-Label Extension (OLE) Demonstrate High Interest in PrEP, Longer-term Evidence of Safety and Efficacy, and No Sign of Increased Risk Behavior Among PrEP Users
International team sheds new light on biology underlying schizophrenia
US Patent Office Grants McCord Research Endothelial Cell Treatment Patent

< Prev Next >
PR Newswire - United Business Media